A bullet type of cancer killer under development

Published: 2004-07-28 06:58:00

Updated: 2004-07-28 06:58:00

Korea Bio Engineering Research Institute and Choongwe Pharm. Co. made an agreement on July 27 for the research and development of an anti-cancer drug, a new conceptional anti-cancer drug that blocks cancer cell's proliferation, and for the exchange of technology informations between two sides.
...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK